Randomized, controlled, parallel-group prospective study to investigate the clinical effectiveness of early insulin treatment in patients with latent autoimmune diabetes in adults

BMC Endocrine Disorders

Volumn 8, Issue , 2008, Pages

  Brophy, Sinead ^a   Davies, Helen ^a   Bain, Stephen ^a   Stephens, Jeffrey W ^a   Cheung, Wei Yee ^a   Richards, Kez ^b   Wareham, Kathie ^b   Beaverstock, Charles ^c   Lloyd, Janet ^d   Page, Don ^d   Williams, Meurig ^e   Russell, Ian ^f   Williams, Rhys ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b ABERTAWE BRO MORGANNWG UNIVERSITY HEALTH BOARD   (United Kingdom)

^c Neath Port Talbot Hospital   (United Kingdom)

^d DIABETES UK   (United Kingdom)

^e PRINCE PHILIP HOSPITAL   (United Kingdom)

^f BANGOR UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; GLITAZONE DERIVATIVE; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; INSULIN ASPART; METFORMIN; ROSIGLITAZONE; SULFONYLUREA;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; DISEASE MARKER; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; EARLY INTERVENTION; EVENING DOSAGE; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LATENT AUTOIMMUNE DIABETES MELLITUS; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORNING DOSAGE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN;

EID: 48949102767     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-8-8     Document Type: Article

References (15)

1. Leslie RD Atkinson MA Notkins AL Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes Diabetologia 1999, 42(1):3-14 10.1007/ s001250051105 10027571
2. Owen KR Stride A Ellard S Hattersley AT Etiological investigation of diabetes in young adults presenting with apparent type 2 diabetes Diabetes Care 2003, 26(7):2088-2093 10.2337/diacare.26.7.2088 12832318
3. Turner R Stratton I Horton V Manley S Zimmet P Mackay IR Shattock M Bottazzo GF Holman R UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group Lancet 1997, 350(9087):1288-1293 10.1016/S0140-6736(97)03062-6 9357409
4. Maruyama T Shimada A Kanatsuka A Kasuga A Takei I Yokoyama J Kobayashi T Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): Preliminary report Ann N Y Acad Sci 2003, 1005:362-369 10.1196/annals.1288.060 14679093
5. Takino H Yamasaki H Sera Y Abe T Ozaki M Kondo H Sakamaki H Kawasaki E Yamaguchi Y Nagataki S Eguchi K The preliminary report from the nation-wide prevention study for type 1 diabetes initially diagnosed as type 2 in Japan Diabetes Metab Rev 1998, 14(4):334-335 10.1002/ (SICI)1099-0895(199812)14:4<334::AID-DMR240>3.0.CO;2-H 10096005
6. Kobayashi T Nakanishi K Murase T Kosaka K Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM Diabetes 1996, 45(5):622-626 10.2337/diabetes.45.5.622 8621013
7. Zhou Z Li X Huang G Peng J Yang L Yan X Wang J Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA) Diabetes Metab Res Rev 2005, 21(2):203-208 10.1002/dmrr.503 15386806
8. Beales PE Pozzilli P Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: Implications for human type 1 diabetes Diabetes Metab Res Rev 2002, 18(2):114-117 10.1002/dmrr.262 11994902
9. Kobayashi T Maruyama T Shimada A Kasuga A Kanatsuka A Takei I Tanaka S Yokoyama J Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus Ann N Y Acad Sci 2002, 958:117-130 12021091
10. Cabrera-Rode E PP Diaz-Horta, Tiberti C, Molina G, Arranz C, Martin J, Licea M, De Leiva A, Puig-Domingo M, Dimario U Slowly progressing type 1 diabetes: Persistence of islet cell autoantibodies is related to glibenclamide treatment Autoimmunity 2002, 35(7):469-474 10.1080/ 0891693021000050574 12685875
11. Brophy S BH Davies H, Mannan S, Williams D.R.R Interventions for latent autoimmune diabetes (LADA) in adults Cochrane Library 2007
12. Bradley C Speight J Patient perceptions of diabetes and diabetes therapy: Assessing quality of life Diabetes Metab Res Rev 2002, 18(Suppl 3):S64-9 10.1002/dmrr.279 12324988
13. Levitt Katz LE Jawad AF Ganesh J Abraham M Murphy K Lipman TH Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis Pediatr Diabetes 2007, 8(2):53-59 10.1111/j.1399-5448.2007.00236.x 17448127
14. Zhu LQ Liu YH Huang M Wei H Liu Z [Study on improvement of islet beta cell function in patients with latent autoimmune diabetes mellitus in adults by integrative Chinese and Western medicine] Zhongguo Zhong Xi Yi Jie He Za Zhi 2004, 24(7):581-584 15307692
15. Saghaei M Random allocation software for parallel group randomized trials BMC Med Res Methodol 2004, 4:26 533876 15535880 10.1186/ 1471-2288-4-26